Varex Imaging Corporation
NMS: VREXLive Quote
📈 ZcoreAI Score
Our AI model analyzes Varex Imaging Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get VREX Z-Score →About Varex Imaging Corporation
Healthcare
Medical Devices
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
📊 Fundamental Analysis
Varex Imaging Corporation demonstrates a profit margin of -7.9%, which is below the sector average, suggesting competitive pressure.
The company recently reported 4.9% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is -12.9%, which indicates that capital utilization is currently under pressure.
At a current price of $11.18, VREX currently sits at the 57th percentile of its 52-week range (Range: $6.76 - $14.56).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$468.66M
Trailing P/E
--
Forward P/E
10.61
Beta (5Y)
1.00
52W High
$14.56
52W Low
$6.76
Avg Volume
327K
Day High
Day Low